ArticleOncology letters2025

Pembrolizumab as an effective treatment for diffuse malignant peritoneal mesothelioma with long‑term survival: A case report and literature review.

Chongxiang Xue et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.